NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors

Leukemia. 2017 Jan;31(1):237-240. doi: 10.1038/leu.2016.250. Epub 2015 Aug 30.

K Byrgazov¹, R Kastner¹, M Gorna², G Hoermann³, M Koenig¹, C B Lucini¹, R Ulreich⁴, M Benesch⁴, V Strenger⁴, H Lackner⁴, W Schwinger⁴, P Sovinz⁴, O A Haas¹, M van den Heuvel-Eibrink^{5

6}, C M Niemeyer⁷, O Hantschel⁸, P Valent⁹, G Superti-Furga², C Urban⁴, M N Dworzak^{1

10}, T Lion^{1

11}

¹ Children's Cancer Research Institute, Vienna, Austria.
² CeMM, Research Center for Molecular Medicine of the Austrian Academy of Science, Vienna, Austria.
³ Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
⁴ Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
⁵ Department of Pediatric Hemato-Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
⁶ Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
⁷ Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
⁸ Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
⁹ Division of Hematology and Hemostaseology, Department of Internal Medicine, Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
¹⁰ St Anna Children's Hospital, Vienna, Austria.
¹¹ Department of Pediatrics, Medical University of Vienna, Vienna, Austria.

No abstract available

Publication types